The pharmaceutical sector continues to rise, with innovation and global expansion emerging as key drivers.
Release date:
2023-03-02
This week, the pharmaceutical and biotechnology index rose 1.88%, outperforming the CSI 300 Index by 0.87 percentage points, with year-to-date gains reaching 3.93%. Sub-sectors such as medical R&D outsourcing, hospitals, and medical equipment delivered particularly strong performances.
This week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming the CSI 300 Index by 0.87 percentage points, marking a year-to-date gain of 3.93%. Sub-sectors such as medical R&D outsourcing, hospitals, and medical equipment delivered particularly strong performances. On the policy front, the "Implementation Plan for Holistic Support of Innovative Drug Development" is steadily being put into practice, with医保 (medical insurance) negotiations achieving a success rate exceeding 90%. Meanwhile, pricing, reimbursement, and hospital access processes for innovative drugs continue to improve. Meanwhile, the National Healthcare Security Administration is encouraging commercial insurers to participate in covering innovative medicines, further refining the diversified payment system. Take BeiGene as an example: its flagship product, zanubrutinib, generated global sales exceeding RMB 8 billion in the first three quarters of 2024, with more than 80% of that revenue coming from European and U.S. markets. As a result, BeiGene’s A-share market capitalization has already surpassed that of Hengrui Medicine. Driven by the dual strategies of "innovation-driven growth" and "global expansion," domestically produced innovative drugs are steadily enhancing their global competitiveness—and are poised to capture an even larger share of the international market in the years ahead.
Next page
Related News
Company Address: Zone C, Specialized & Innovative Chemical Industry Incubation Base, West Section of Yili River Street, No. 436, Qinchuan Town, Qinchuan Park, Lanzhou New Area, Gansu Province
Mobile Phone Official Website